CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
VSEE VSee Health
- 1.231
- -0.019-1.50%
Close Apr 29 16:00 ET
19.29MMarket Cap-1.24P/E (TTM)
1.280High1.230Low5.97KVolume1.250Open1.250Pre Close7.50KTurnover0.09%Turnover RatioLossP/E (Static)15.66MShares33.08052wk High4.05P/B7.97MFloat Cap1.00052wk Low--Dividend TTM6.48MShs Float33.080Historical High--Div YieldTTM4.00%Amplitude1.000Historical Low1.256Avg Price1Lot Size
About VSee Health Company
VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.
Company Profile
SymbolVSEE
Company NameVSee Health
Listing DateDec 31, 2021
CEOMr. Milton Chen
MarketNASDAQ
Employees119
Fiscal Year Ends12-31
Address980 North Federal Highway,Suite 304
CityBoca Raton
ProvinceFlorida
CountryUnited States of America
Zip Code33432
Phone1-561-672-7068
Websitehttp://www.vseehealth.com
Company Executives
- Name
- Position
- Salary
- Milton Chen
- Co-Chief Executive Officer and Director
- --
- Dr. Imoigele Aisiku
- Co-Chief Executive Officer and Chairman of the Board
- --
- Jerry Leonard
- Chief Financial Officer and Secretary
- --
- George McNellage
- Chief Operating Officer and Director, Sales
- --
- Scott Metzger
- Independent Director
- --
- Kevin Lowdermilk
- Independent Director
- --
- Colin O’Sullivan
- Independent Director
- --
- Cydonii V. Fairfax
- Independent Director
- --
- David L. Wickersham
- Independent Director
- --
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call